应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02268 药明合联
已收盘 02-23 16:08:03
66.950
+1.450
+2.21%
最高
67.550
最低
65.500
成交量
107.46万
今开
65.500
昨收
65.500
日振幅
3.13%
总市值
842.23亿
流通市值
842.23亿
总股本
12.58亿
成交额
7,205万
换手率
0.09%
流通股本
12.58亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
药明合联02月16日遭主力抛售211.9万元
市场透视 · 02-16
药明合联02月16日遭主力抛售211.9万元
每日卖空追踪 | 药明合联 02月12日卖空量成交25.95万股,卖空比例为6.27%
市场透视 · 02-12
每日卖空追踪 | 药明合联 02月12日卖空量成交25.95万股,卖空比例为6.27%
大行评级丨野村:上调药明合联目标价至87.73港元,预计今年盈利将升47%
中金财经 · 02-12
大行评级丨野村:上调药明合联目标价至87.73港元,预计今年盈利将升47%
药明合联(2268)、东曜药业(1875)联合公告:寄发自愿有条件现金要约综合文件
公告速递 · 02-12
药明合联(2268)、东曜药业(1875)联合公告:寄发自愿有条件现金要约综合文件
药明合联生物技术有限公司与东曜药业股份有限公司联合公告:要约收购相关事宜
金吾财讯 · 02-12
药明合联生物技术有限公司与东曜药业股份有限公司联合公告:要约收购相关事宜
药明合联(2268)拟以每股4港元收购东曜药业(1875)全部股份并注销未行使购股权
公告速递 · 02-12
药明合联(2268)拟以每股4港元收购东曜药业(1875)全部股份并注销未行使购股权
医药行业周报:1-8批国采平稳接续扰动有限 机构加仓创新 持续看好低估创新标的
交银国际 · 02-12
医药行业周报:1-8批国采平稳接续扰动有限 机构加仓创新 持续看好低估创新标的
每日卖空追踪 | 药明合联 02月10日卖空量成交14.95万股,卖空比例为2.58%
市场透视 · 02-10
每日卖空追踪 | 药明合联 02月10日卖空量成交14.95万股,卖空比例为2.58%
恒生医疗保健指数升2.17% 医药板块普遍拉升 机构持续看好中国创新药出海的产业趋势
金吾财讯 · 02-10
恒生医疗保健指数升2.17% 医药板块普遍拉升 机构持续看好中国创新药出海的产业趋势
高盛:今年内地医疗板块更依赖数据及盈利能见度 看好CDMO企业
智通财经 · 02-09
高盛:今年内地医疗板块更依赖数据及盈利能见度 看好CDMO企业
每日卖空追踪 | 药明合联 02月06日卖空量成交16.1万股,卖空比例为3.82%
市场透视 · 02-06
每日卖空追踪 | 药明合联 02月06日卖空量成交16.1万股,卖空比例为3.82%
交银国际:预计医药板块今年持续稳中向好 建议寻找被低估医药股
智通财经 · 02-05
交银国际:预计医药板块今年持续稳中向好 建议寻找被低估医药股
药明合联生物技术有限公司延迟寄发通函
金吾财讯 · 02-04
药明合联生物技术有限公司延迟寄发通函
药明合联02月04日遭主力抛售620.9万元
市场透视 · 02-04
药明合联02月04日遭主力抛售620.9万元
药明合联(2268)1月股份变动月报表:股本增加2,751,719股
公告速递 · 02-03
药明合联(2268)1月股份变动月报表:股本增加2,751,719股
每日卖空追踪 | 药明合联 02月03日卖空量成交24.75万股,卖空比例为7.55%
市场透视 · 02-03
每日卖空追踪 | 药明合联 02月03日卖空量成交24.75万股,卖空比例为7.55%
药明合联01月30日主力净流出87.3万元 散户资金买入
市场透视 · 01-30
药明合联01月30日主力净流出87.3万元 散户资金买入
每日卖空追踪 | 药明合联 01月29日卖空量成交14.7万股,卖空比例为4.36%
市场透视 · 01-29
每日卖空追踪 | 药明合联 01月29日卖空量成交14.7万股,卖空比例为4.36%
每日卖空追踪 | 药明合联 01月28日卖空量成交6.1万股,卖空比例为1.32%
市场透视 · 01-28
每日卖空追踪 | 药明合联 01月28日卖空量成交6.1万股,卖空比例为1.32%
药明合联01月28日主力净流出383.1万元 散户资金买入
市场透视 · 01-28
药明合联01月28日主力净流出383.1万元 散户资金买入
加载更多
公司概况
公司名称:
药明合联
所属市场:
SEHK
上市日期:
--
主营业务:
药明合联生物技术有限公司是一家主要从事提供提供抗体偶联药物(ADC)及其他生物偶联药物的全面合同研究、开发及制造组织(CRDMO)服务的投资控股公司。该公司的服务包括生物偶联药物、单克隆抗体中间体及生物偶联药物相关连接子及有效载荷的发现、工艺开发及优良生产质量管理规范(GMP)生产。该公司透过按有偿服务(FFS)基准的合约和按全时当量(FTE)基准的合约向客户提供CRDMO服务。该公司主要在国内市场、北美、欧洲和世界其他地区市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"药明合联","latestPrice":66.95,"timestamp":1771834083005,"preClose":65.5,"halted":0,"volume":1074602,"delay":0,"changeRate":0.022137404580152713,"floatShares":1258000000,"shares":1258000000,"eps":0.9424700717921453,"marketStatus":"已收盘","change":1.45,"latestTime":"02-23 16:08:03","open":65.5,"high":67.55,"low":65.5,"amount":72049674,"amplitude":0.031298,"askPrice":67,"askSize":4500,"bidPrice":66.95,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":1.1588807646152761,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":65.5,"openAndCloseTimeList":[[1771810200000,1771819200000],[1771822800000,1771833600000]],"volumeRatio":0.311393,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02268","defaultTab":"news","newsList":[{"id":"2612847734","title":"药明合联02月16日遭主力抛售211.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612847734","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612847734?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:15","pubTimestamp":1771229731,"startTime":"0","endTime":"0","summary":"02月16日, 药明合联股价跌0.46%,报收65.00元,成交金额5556.5万元,换手率0.07%,振幅2.45%,量比0.20。药明合联今日主力资金净流出211.9万元,上一交易日主力净流出960.0万元。该股近5个交易日上涨3.59%,主力资金累计净流出1103.1万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出2520.9万元,其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216161642a700d466&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216161642a700d466&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","SG9999014674.SGD","02268","LU2488822045.USD"],"gpt_icon":0},{"id":"2610926836","title":"每日卖空追踪 | 药明合联 02月12日卖空量成交25.95万股,卖空比例为6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610926836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610926836?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:30","pubTimestamp":1770885029,"startTime":"0","endTime":"0","summary":"药明合联北京时间02月12日,跌1%,卖空量成交25.95万股,较上一交易日减少64.93%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163402a49b9f7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163402a49b9f7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","BK1141","02268","LU2488822045.USD"],"gpt_icon":0},{"id":"2610154489","title":"大行评级丨野村:上调药明合联目标价至87.73港元,预计今年盈利将升47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610154489","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610154489?lang=zh_cn&edition=full","pubTime":"2026-02-12 14:07","pubTimestamp":1770876421,"startTime":"0","endTime":"0","summary":"野村发表研报,将药明合联2025年收入及盈利预测分别下调4.5%及8.7%,以反映公司上月公布的实际数据。同时,该行预计来自商业化阶段项目的收入为1.81亿元,而收购东曜药业带来的收入则为1.5亿元。利润方面,该行预计2026年盈利将升47%;毛利率按年扩张0.7个百分点至36.5%,基于规模经济效应,但新加坡厂房的折旧将带来轻微拖累;经营利润率按年扩张1.1个百分点至29.3%,反映效率提升。该行将药明合联目标价由82.72港元上调至87.73港元,评级“买入”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260212/32014586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02268"],"gpt_icon":0},{"id":"1144275849","title":"药明合联(2268)、东曜药业(1875)联合公告:寄发自愿有条件现金要约综合文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1144275849","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144275849?lang=zh_cn&edition=full","pubTime":"2026-02-12 06:52","pubTimestamp":1770850322,"startTime":"0","endTime":"0","summary":"药明合联生物技术有限公司与东曜药业股份有限公司于2026年2月12日联合发布公告,宣布寄发有关自愿有条件现金要约的综合文件。该要约由花旗环球金融亚洲有限公司代表要约人,拟收购除要约人及其一致行动人士已拥有或同意收购以外的全部已发行股份,并注销全部尚未行使的购股权。综合文件包含要约详情、独立董事委员会及独立财务顾问意见、接受程序及预期时间表等内容。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"2610710967","title":"药明合联生物技术有限公司与东曜药业股份有限公司联合公告:要约收购相关事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=2610710967","media":"金吾财讯","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610710967?lang=zh_cn&edition=full","pubTime":"2026-02-12 06:43","pubTimestamp":1770849815,"startTime":"0","endTime":"0","summary":"公告指出,综合文件及随附的接纳表格将于2026年2月12日寄送给股东和购股权持有人,要约亦于同日正式启动。同时,公告提醒股东、受限制股份奖励持有人和购股权持有人,在收到综合文件及随附的接纳表格后,应仔细阅读相关内容,并根据独立财务顾问的意见及独立董事委员会的建议,审慎决定是否接受要约。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212070618a499a13a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212070618a499a13a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02268","BK1141","01875","LU2488822045.USD","SG9999014674.SGD","BK1161"],"gpt_icon":1},{"id":"1175233464","title":"药明合联(2268)拟以每股4港元收购东曜药业(1875)全部股份并注销未行使购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1175233464","media":"公告速递","labels":["corporation","merge","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175233464?lang=zh_cn&edition=full","pubTime":"2026-02-12 06:41","pubTimestamp":1770849670,"startTime":"0","endTime":"0","summary":"2026年2月12日,药明合联生物技术有限公司与东曜药业股份有限公司联合公布一份自愿有条件现金要约方案。公告显示,药明合联方面通过财务顾问花旗环球金融亚洲有限公司,提议以每股4.00港元的现金价格收购东曜药业已发行的所有股份,并同时注销全部未行使的购股权。本次收购要约价较东曜药业在公告前的部分平均价格有溢价,药明合联某些股东同时也签订缺额承诺,以确保在接纳不足时可再行提出接纳。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"2610250289","title":"医药行业周报:1-8批国采平稳接续扰动有限 机构加仓创新 持续看好低估创新标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2610250289","media":"交银国际","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610250289?lang=zh_cn&edition=full","pubTime":"2026-02-12 00:00","pubTimestamp":1770825600,"startTime":"0","endTime":"0","summary":"本周内外资继续重点加仓创新药械产业链:1)内资重点加仓泰格医药、康龙化成、药明生物等受益于需求复苏的龙头CXO 企业,以及一脉阳光、方舟健客等AI 赋能的器械和服务类标的;2 外资亦加仓低估值创新药械企业,包括亿腾生物、石药集团和MIRXES 等,以及凯莱英、昭衍新药等CXO 企业。投资启示:本周1-8 批国采平稳接续,整体中选率高达93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212202658a6f36bb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212202658a6f36bb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999014674.SGD","02268","BK1141"],"gpt_icon":0},{"id":"2610984330","title":"每日卖空追踪 | 药明合联 02月10日卖空量成交14.95万股,卖空比例为2.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610984330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610984330?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:30","pubTimestamp":1770712231,"startTime":"0","endTime":"0","summary":"药明合联北京时间02月10日,涨3.51%,卖空量成交14.95万股,较上一交易日减少35.14%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163422a6e9add0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163422a6e9add0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","BK1141","LU2488822045.USD","02268"],"gpt_icon":0},{"id":"2610268695","title":"恒生医疗保健指数升2.17% 医药板块普遍拉升 机构持续看好中国创新药出海的产业趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2610268695","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610268695?lang=zh_cn&edition=full","pubTime":"2026-02-10 09:59","pubTimestamp":1770688793,"startTime":"0","endTime":"0","summary":"2月8日,信达生物宣布与礼来制药达成战略合作,携手推进肿瘤及免疫领域创新药物的全球研发。2026年,继续看好中国创新药出海的产业趋势,继续重点跟踪ADC、双抗、小核酸、减肥药等核心优势赛道的投资机会,期待JPM大会、ASCO等带来数据更新和BD催化。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8f73ea90e21e93e4b02cf2f8986a9c30","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974845","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","LU0634319403.HKD","LU0516422366.SGD","BK1587","LU0823426308.USD","LU0196878994.USD","LU0140636845.USD","02696","06978","LU0359202008.SGD","LU1969619763.USD","02268","LU2039709279.SGD","02269","LU1961090484.USD","LU1720050803.USD","BK1161","LU2476274308.USD","09939","LU0417516902.SGD","159992","03347","02162","01548","LU0502904849.HKD","LU2242644610.SGD","LU2488822045.USD","LU2045819591.USD","09688","LU0348825331.USD","LU0572944931.SGD","IE00B5MMRT66.SGD","LU0181495838.USD","LU0417516738.SGD","LU0516423174.USD","02359","01877","01801","159938","06990","LU0051755006.USD","09926","159506","LU0856984785.SGD","LU0043850808.USD","HK0000306701.USD","LU1046422090.SGD","LU2476274720.SGD","LU1688375341.USD","09969"],"gpt_icon":1},{"id":"2610568695","title":"高盛:今年内地医疗板块更依赖数据及盈利能见度 看好CDMO企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2610568695","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610568695?lang=zh_cn&edition=full","pubTime":"2026-02-09 14:08","pubTimestamp":1770617323,"startTime":"0","endTime":"0","summary":"今年要获得超越行业的回报,更依赖于关键数据公布、实际成交,以及盈利兑现或转折点的能见度。该行对医疗器械板块维持中性看法,虽然行业已触底,但需时逐步复苏;推荐买时代天使及威高股份。医疗服务板块方面,该行仍持相对谨慎态度,因成本控制措施的持续影响,以及疲弱的消费周期;下调海吉亚医疗评级至“中性”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0708995583.HKD","BK1161","BK1589","02359","BK4139","HK0000165453.HKD","LU0196878994.USD","BK1576","06990","LU2488822045.USD","159891","CDMO","LU2125910500.SGD","03692","HK0000320223.HKD","02696","LU1046422090.SGD","HK0000306685.HKD","02268","HK0000320264.USD","LU2045819591.USD","HK0000306701.USD","BK1141","LU0320764599.SGD","SG9999014674.SGD","LU2242644610.SGD","BK1191","LU0052750758.USD","BK1583"],"gpt_icon":0},{"id":"2609690505","title":"每日卖空追踪 | 药明合联 02月06日卖空量成交16.1万股,卖空比例为3.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609690505","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609690505?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:30","pubTimestamp":1770366630,"startTime":"0","endTime":"0","summary":"药明合联北京时间02月06日,涨1.45%,卖空量成交16.1万股,较上一交易日减少72.57%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163440a483cf24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163440a483cf24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","BK1141","LU2488822045.USD","SG9999014674.SGD"],"gpt_icon":0},{"id":"2609327740","title":"交银国际:预计医药板块今年持续稳中向好 建议寻找被低估医药股","url":"https://stock-news.laohu8.com/highlight/detail?id=2609327740","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609327740?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:54","pubTimestamp":1770281655,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,交银国际发布研报称,恒生医疗保健指数本周累跌3.3%,表现跑输大市,去年第四季至今内资通过港股通持有医药股的比例亦出现轻微下降,外资持仓则有所提升,部分加仓创新药械及受惠于需求复苏的龙头CXO企业。在今年医药业务拓展中,交银国际建议关注小核酸、长效制剂、invivo CAR-T、新一代ADC/XDC等差异化平台,以及自免、代谢、CNS等疾病领域,认为该板块稳中向好的趋势将于今年延续,但仍有可能出现短期波动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1593","BK1515","BK1191","BK1161","01530","03329","BK1588","SG9999014674.SGD","BK1147","LU2488822045.USD","BK1574","BK1141","02595","02268","00013","BK1583","159938","HK0000165453.HKD","09939"],"gpt_icon":0},{"id":"2609323986","title":"药明合联生物技术有限公司延迟寄发通函","url":"https://stock-news.laohu8.com/highlight/detail?id=2609323986","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609323986?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:54","pubTimestamp":1770216845,"startTime":"0","endTime":"0","summary":"金吾财讯|2026年2月4日,药明合联生物技术有限公司发布延迟寄发通函公告。此前,药明合联生物技术有限公司、药明生物技术有限公司及东曜药业股份有限公司于2026年1月14日联合刊发有关要约的公告。联交所已基于公司承诺于2026年2月13日或之前寄发通函,向公司授出豁免。公告强调,若公司情况出现变动,联交所可能更改或撤回豁免。药明合联生物技术有限公司董事会包括多名执行董事、非执行董事及独立非执行董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204232312a47c74f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204232312a47c74f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","BK1141","02268","LU2488822045.USD"],"gpt_icon":0},{"id":"2609323954","title":"药明合联02月04日遭主力抛售620.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609323954","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609323954?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192929,"startTime":"0","endTime":"0","summary":"02月04日,药明合联股价收平报60.60元,成交金额5.0亿元,换手率0.67%,振幅5.78%,量比1.76。药明合联今日主力资金净流出620.9万元,上一交易日主力净流出198.3万元。该股近5个交易日下跌7.34%,主力资金累计净流入2330.0万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入5054.7万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161716a47afa16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161716a47afa16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","BK1141","LU2488822045.USD","SG9999014674.SGD"],"gpt_icon":0},{"id":"1158879219","title":"药明合联(2268)1月股份变动月报表:股本增加2,751,719股","url":"https://stock-news.laohu8.com/highlight/detail?id=1158879219","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158879219?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:50","pubTimestamp":1770108652,"startTime":"0","endTime":"0","summary":"2026年2月3日,WuXi XDC Cayman Inc.披露截至2026年1月31日的股份变动月报表。报告期内,法定股本保持在10,000,000,000股,面值每股0.00005美元,总额500,000美元未发生变动。报告期初已发行股份总数为1,255,240,986股,期末增至1,257,992,705股,新增2,751,719股。公司确认符合香港联交所对公众持股量的相关要求。根据公告,新增股份主要来自期权行使,涉及数量共计2,751,719股。另有2024年股份计划所授出的潜在股份10,285,226股尚未正式发行。公司声明遵守香港联交所《上市规则》及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"2608334554","title":"每日卖空追踪 | 药明合联 02月03日卖空量成交24.75万股,卖空比例为7.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608334554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608334554?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:30","pubTimestamp":1770107429,"startTime":"0","endTime":"0","summary":"药明合联北京时间02月03日,涨0.83%,卖空量成交24.75万股,较上一交易日减少71.4%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163458a6cdb7f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163458a6cdb7f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","SG9999014674.SGD","02268","LU2488822045.USD"],"gpt_icon":0},{"id":"2607509780","title":"药明合联01月30日主力净流出87.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2607509780","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607509780?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:15","pubTimestamp":1769760914,"startTime":"0","endTime":"0","summary":"01月30日, 药明合联股价跌2.56%,报收62.80元,成交金额4.0亿元,换手率0.51%,振幅3.72%,量比1.91。药明合联今日主力资金净流出87.3万元,上一交易日主力净流入289.4万元。该股近5个交易日下跌8.96%,主力资金累计净流出1294.8万元;近20日主力资金累计净流入3091.0万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130161546a6bf3070&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130161546a6bf3070&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","LU2488822045.USD","02268","SG9999014674.SGD"],"gpt_icon":0},{"id":"2607803097","title":"每日卖空追踪 | 药明合联 01月29日卖空量成交14.7万股,卖空比例为4.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607803097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607803097?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:30","pubTimestamp":1769675430,"startTime":"0","endTime":"0","summary":"药明合联北京时间01月29日,跌1.45%,卖空量成交14.7万股,较上一交易日减少53.04%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164013a6bae327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164013a6bae327&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","BK1141","LU2488822045.USD","SG9999014674.SGD"],"gpt_icon":0},{"id":"2607285957","title":"每日卖空追踪 | 药明合联 01月28日卖空量成交6.1万股,卖空比例为1.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607285957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607285957?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:30","pubTimestamp":1769589029,"startTime":"0","endTime":"0","summary":"药明合联北京时间01月28日,跌0.91%,卖空量成交6.1万股,较上一交易日减少79.97%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164812a45f8c24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164812a45f8c24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02268","SG9999014674.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2607728557","title":"药明合联01月28日主力净流出383.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2607728557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607728557?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:15","pubTimestamp":1769588158,"startTime":"0","endTime":"0","summary":"01月28日, 药明合联股价跌0.91%,报收65.40元,成交金额3.0亿元,换手率0.37%,振幅2.65%,量比1.60。药明合联今日主力资金净流出383.1万元,上一交易日主力净流入252.9万元。该股近5个交易日下跌3.54%,主力资金累计净流出1102.7万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入2567.4万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162615a45f772c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162615a45f772c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999014674.SGD","BK1141","02268"],"gpt_icon":0}],"profile":{"websiteUrl":"http://wuxixdc.com","stockEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":-0.0339},{"period":"3month","weight":-0.0143},{"period":"6month","weight":0.1352},{"period":"1year","weight":0.8094},{"period":"ytd","weight":0.0782}],"compareEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":-0.0065},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0424},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0305}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明合联生物技术有限公司是一家主要从事提供提供抗体偶联药物(ADC)及其他生物偶联药物的全面合同研究、开发及制造组织(CRDMO)服务的投资控股公司。该公司的服务包括生物偶联药物、单克隆抗体中间体及生物偶联药物相关连接子及有效载荷的发现、工艺开发及优良生产质量管理规范(GMP)生产。该公司透过按有偿服务(FFS)基准的合约和按全时当量(FTE)基准的合约向客户提供CRDMO服务。该公司主要在国内市场、北美、欧洲和世界其他地区市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":0.010265},{"month":2,"riseRate":0.666667,"avgChangeRate":0.058284},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.010372},{"month":4,"riseRate":0.555556,"avgChangeRate":0.03555},{"month":5,"riseRate":0.333333,"avgChangeRate":0.006014},{"month":6,"riseRate":0.4,"avgChangeRate":-0.032735},{"month":7,"riseRate":0.4,"avgChangeRate":0.011785},{"month":8,"riseRate":0.4,"avgChangeRate":-0.114063},{"month":9,"riseRate":0.333333,"avgChangeRate":0.019767},{"month":10,"riseRate":0.777778,"avgChangeRate":0.151657},{"month":11,"riseRate":0.333333,"avgChangeRate":0.008796},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.068876}],"exchange":"SEHK","name":"药明合联","nameEN":"WUXI XDC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明合联,02268,药明合联股票,药明合联股票老虎,药明合联股票老虎国际,药明合联行情,药明合联股票行情,药明合联股价,药明合联股市,药明合联股票价格,药明合联股票交易,药明合联股票购买,药明合联股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}